Jump to content

ATC code L02

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 15:35, 25 March 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

ATC code L: Antineoplastic and immunomodulating agents
Other ATC codes

ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL02.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

L02AA Estrogens

L02AA01 Diethylstilbestrol
L02AA02 Polyestradiol phosphate
L02AA03 Ethinylestradiol
L02AA04 Fosfestrol

L02AB Progestogens

L02AB01 Megestrol
L02AB02 Medroxyprogesterone
L02AB03 Gestonorone

L02AE Gonadotropin-releasing hormone analogues

L02AE01 Buserelin
L02AE02 Leuprorelin
L02AE03 Goserelin
L02AE04 Triptorelin
L02AE05 Histrelin

L02AX Other hormones

L02BA Anti-estrogens

L02BA01 Tamoxifen
L02BA02 Toremifene
L02BA03 Fulvestrant

L02BB Anti-androgens

L02BB01 Flutamide
L02BB02 Nilutamide
L02BB03 Bicalutamide
L02BB04 Enzalutamide

L02BG Aromatase inhibitors

L02BG01 Aminogluthetimide
L02BG02 Formestane
L02BG03 Anastrozole
L02BG04 Letrozole
L02BG05 Vorozole
L02BG06 Exemestane
L02BX01 Abarelix
L02BX02 Degarelix
L02BX03 Abiraterone

References

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code L02". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QL02". WHO Collaborating Centre for Drug Statistics Methodology.
Retrieved from "https://en.wikipedia.org/w/index.php?title=ATC_code_L02&oldid=832367842"